Market Overview

TherapeuticsMD, Inc. (TXMD)

1.60 -0.01 (-0.62%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.21
12.251M



Q4 2020
Pre-Market
EPS:
REV:
-0.19
15.902M



Q3 2020
After-Hours
EPS:
REV:
-0.13
23.72M



Q2 2020
Pre-Market
EPS:
REV:
-0.19
6.079M
-0.17
10.2M
-0.19
10.701M
-11.76%
4.91%
Q1 2020
Pre-Market
EPS:
REV:
-0.16
3.947M
-0.19
11.3M
-0.21
12.251M
-10.53%
8.42%
Q4 2019
Pre-Market
EPS:
REV:
-0.17
5.09M
-0.19
12.83M
-0.19
15.902M
0%
23.94%
Q3 2019
After-Hours
EPS:
REV:
-0.16
3.473M
-0.19
8.14M
-0.13
23.72M

191.4%
Q2 2019
After-Hours
EPS:
REV:
-0.15
3.763M
-0.17
5.12M
-0.19
6.079M
-11.76%
18.73%
Q1 2019
After-Hours
EPS:
REV:
-0.11
3.773M
-0.17
5.89M
-0.16
3.947M
5.88%
-32.99%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!